GM-CSF: more than a growth factor.
Till
R
R
Novartis, Basle, Switzerland.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001709:Biotechnology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis / Q000235:genetics / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000188:drug therapy; D015202:Protein Engineering; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim